Recalcitrant nAMD/DME: How Much Fluid Can We Tolerate?

Recalcitrant nAMDDME How Much Fluid Can We Tolerate
Media formats available:
Details
Presenters
  • Overview

    Join Nancy M. Holekamp, MD, and Julia A. Haller, MD, for a comprehensive discussion about persistent cases of neovascular age-related macular degeneration and diabetic macular edema. They share their expertise on treatment approaches and discussions with patients.

    This activity is supported by an unrestricted educational grant from Genentech, a member of the Roche Group.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Discuss current and future therapeutic agents for diabetic eye disease and neovascular AMD, and the implications for patient outcomes
    • Accreditation

      This educational activity is provided by Evolve Medical Education LLC (Evolve).

      Accreditation Statement
      Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

      Credit Designation Statement
      Evolve designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

       

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Nancy M. Holekamp, MD

      Nancy M. Holekamp, MD

      Director, Retina Services
      Pepose Vision Institute
      Chesterfield, MO


      Julia A. Haller, MD

      Julia A. Haller, MD

      Ophthalmologist-in-Chief  
      William Tasman, MD, Endowed Chair
      Wills Eye Hospital
      Professor and Chair of Ophthalmology
      Thomas Jefferson University
      Philadelphia, PA


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Nancy M. Holekamp, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, Annexon, Apellis, Bayer, Cardinal, Clearside Biosciences, EyePoint Pharmaceuticals, Gemini Therapeutics, Gyroscope, Katalyst Surgical, Nacuity, NGM, Notal Vision, Novartis, Ocuphire, Outlook Therapeutics, Regeneron Pharmaceuticals, Stealth Biosciences, and Thea Laboratoires. Grant/Research Support: Gemini Therapeutics, Genentech, Gyroscope, and Notal Vision. Speaker’s Bureau: Allergan, Apellis, Genentech, Regeneron Pharmaceuticals, and Spark Therapeutics. Stock/Shareholder: Gemini Therapeutics, Katalyst Surgical, and Nacuity.

      Julia A. Haller, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aura Biosciences, Lowy Medical Research Institute, Regeneron Pharmaceuticals, and Seeing Medicines. Advisory Board: Bristol Myers-Squibb, Eyenovia, and Opthea. Stock/Shareholder: Bristol Myers-Squibb, Eyenovia, and Opthea.

       

      The Evolve staff and planners have no financial relationships with ineligible companies.
      Nisha Mukherjee, MD, peer reviewer, has no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Genentech, a member of the Roche Group.

       

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free